SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Vatera Capital Management LLC

(Last) (First) (Middle)
400 ROYAL PALM WAY, SUITE 212

(Street)
PALM BEACH FL 33480

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/02/2019
3. Issuer Name and Ticker or Trading Symbol
MELINTA THERAPEUTICS, INC. /NEW/ [ MLNT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 16,007,237 I Held by Vatera Healthcare Partners LLC(1)
Common Stock 600,722 I Held by VHPM Holdings LLC(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On January 2, 2019 Vatera Capital Management LLC ("VCM") was appointed as the manager of Vatera Healthcare Partners LLC and VHPM Holdings LLC. Kevin Ferro serves as the Chief Executive Officer and Managing Member of VCM. Pursuant to Rule 13d-3 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act"), VCM may be deemed to beneficially own the shares held directly by Vatera Healthcare Partners LLC and VHPM Holdings LLC. VCM disclaims beneficial ownership of any shares owned by Vatera Healthcare Partners LLC or VHPM Holdings LLC, except to the extent of its pecuniary interest therein. Mr. Ferro serves on the Board of Directors of the Issuer (the "Board"). Solely for the purposes of Section 16 of the Exchange Act, VCM may be deemed to be a director-by-deputization as a result of the service of Mr. Ferro on the Board.
Remarks:
Vatera Capital Management LLC, By: /s/ Kevin Ferro, Title: Chief Executive Officer and Managing Member 01/11/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.